NCELNASDAQHealthcare · Biotechnology

NewcelX Ltd.

$3.25+2.20%(+$0.07)

TickerSpark Score

54/100

Mixed

100

Valuation

Profitability

Growth

Health

Momentum

Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a NCEL research report →

52-Week Range5% of range

Low $1.83

Current $3.25

High $30.80

Companywww.newcelx.com

NewcelX Ltd., a biotechnology company, engages in developing transformative cell-based and small-molecule therapies for neurodegenerative and metabolic diseases. The company was founded in 2008 and is headquartered in Zurich, Switzerland.

CEO: Ronen Twito
IPO: 2025
Employees: 11
HQ: Zurich, CH

Price Chart

-81.21% · this period

Valuation

Market Cap: $1.46M
P/E: -0.60
P/S: 0.00
P/B: 0.45
EV/EBITDA: 0.42
Div Yield: 0.00%

Profitability

Gross Margin: 0.00%
Op Margin: 0.00%
Net Margin: 0.00%
ROE: -100.99%
ROIC: -142.44%

Growth & Income

Revenue: $0 · 0.00%
Net Income: $-1,980,810 · 83.73%
EPS: $-26.30 · -721.88%
Op Income: $-4,380,113
FCF YoY: 55.89%

Performance & Tape

52W High: $30.80
52W Low: $1.83
50D MA: $2.93
200D MA: $8.32
Beta: 1.00
Avg Volume: 39.15K

Get TickerSpark's AI analysis on NCEL

Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

30-day money-back guarantee · cancel anytime

Recent Insider Transactions

Date	Insider	Role	Type	Shares	Value
Apr 27, 26	Samuel Olivier	director	buy	114,545	$346.50K
Apr 27, 26	Samuel Olivier	director	buy	81,818	$225.00K
Apr 27, 26	Revel Michel	director, 10 percent owner, officer: CSO and Director	buy	54,545	$150.00K
Apr 27, 26	Revel Michel	director, 10 percent owner, officer: CSO and Director	buy	76,363	$231.00K
Mar 18, 26	Galili Tamar	director	other	9,117	$69.47K
Mar 18, 26	Twito Ronen	director, officer: Chairman and CEO	other	0	—
Mar 18, 26	Revel Michel	director, officer: CSO and Director	other	0	—
Mar 18, 26	Revel Michel	director, officer: CSO and Director	other	9,117	$69.47K
Mar 18, 26	Hagai Omri	officer: Chief Financial Officer	other	11,396	$86.84K
Mar 18, 26	Samuel Olivier	director	other	13,676	$104.21K